Hypertension Optimal Treatment (HOT) Study: Home Blood Pressure in Treated Hypertensive Subjects
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Abstract —The Hypertension Optimal Treatment Study is a prospective trial conducted in 26 countries. The aims are to (1) evaluate the relationship between three levels of target office diastolic blood pressure (BP) (≤80, ≤85, or ≤90 mm Hg) and cardiovascular morbidity and mortality in hypertensive patients and (2) examine the effects on cardiovascular morbidity and mortality of 75 mg aspirin daily versus placebo. A total of 19 193 patients between 50 and 80 years of age had been randomized by the end of April 1994. Treatment was initiated with felodipine 5 mg daily, and additional therapy was given in accordance with a set protocol. The present substudy of 926 patients performed in nine countries aimed to (1) compare home with office BP in a representative subsample of the HOT population after the titration of treatment was completed and (2) clarify whether the separation into the target groups could be expanded into the out-of-office setting. The differences between office and home measurements in diastolic BP of 0.2 mm Hg (SD, 9; 95% confidence interval, −0.36 to 0.81; P =.40) and systolic BP of 0.5 mm Hg (SD, 15; 95% confidence interval, −0.53 to 1.46; P =.21) were not significant. The group differences in home BP were 1.9 mm Hg (≤80 versus ≤85) and 1.2 mm Hg (≤85 versus ≤90) for diastolic BP (F=11.69; ANOVA, P <.0001) and 2.6 and 2.1 mm Hg for systolic BP (F=8.44, P =.0002). Thus, office and home BPs measured with the same semiautomatic device are comparable in treated hypertensive subjects in the HOT Study, and the separation into the target groups based on office readings prevails at home.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Extension of Multiple Range Tests to Group Means with Unequal Numbers of Replications
Kramer, C. Y. (1956) · Biometrics · doi:10.2307/3001469 · Cited by 3,146
Cited by
Agarwal, R., Bills, J. E., Hecht, T. J. W., & Light, R. P. (2011) · Hypertension · doi:10.1161/hypertensionaha.110.160911 · Cited by 430
Diagnosis and management of hypertension in adults: NICE guideline update 2019
Jones, N. R., McCormack, T., Constanti, M., & McManus, R. J. (2020) · British Journal of General Practice · doi:10.3399/bjgp20x708053 · Cited by 249
Kjeldsen, S. E., Lund-Johansen, P., Nilsson, P. M., & Mancia, G. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.07257 · Cited by 208
Self-citationAgarwal, R., & Andersen, M. J. (2006) · Kidney International · doi:10.1038/sj.ki.5000081 · Cited by 184
Eguchi, K., Kuruvilla, S., Ogedegbe, G., Gerin, W., Schwartz, J. E., & Pickering, T. G. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e32832a6e39 · Cited by 53
Metadata
- Authors
- Kjeldsen, S. E., Hedner, T., Jamerson, K., Julius, S., Haley, W. E., Zabalgoitia, M., Butt, A. R., Rahman, S. N., & Hansson, L.
- Venue
- Hypertension
- Published
- 1998-04
- Volume
- 31
- Issue
- 4
- Pages
- 1014-1020
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2043697045
- Cited by
- 72
- References
- 1
- FWCI
- 2.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hypertension Optimal Treatment (HOT) Study: Home Blood Pressure in Treated Hypertensive Subjects. https://app.cochat.ai/papers/10.1161/01.hyp.31.4.1014
- The paper
- Kjeldsen, S. E., Hedner, T., Jamerson, K., Julius, S., Haley, W. E., Zabalgoitia, M., Butt, A. R., Rahman, S. N., & Hansson, L. (1998). Hypertension Optimal Treatment (HOT) Study: Home Blood Pressure in Treated Hypertensive Subjects. Hypertension. https://doi.org/10.1161/01.hyp.31.4.1014
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.